|
Research
The
R&D division is engaged in the development of
products and processes and transferring the
technologies to production section. The focus is on
infectious diseases of animals and human beings with
the aim to bring out economical products in the
health care segment.
From a one-product company IIL
has grown to a multi-product company because of its
in-house R&D and process development. Scientists
from various disciplines such as microbiology,
biotechnology, pharmacy and biochemistry work on
novel and conventional technologies to develop
vaccines, diagnostics, monoclonal antibodies and
biologicals.
Collaborations with national and
international organizations help to bring in the
latest concepts and methods in product development.
Progress in various projects is reviewed by the
research director and the scientific advisory
committee to monitor and provide over all guidance.
Scientists working in various projects interact and
complement each other’s technical knowledge and
skills. This provides a vibrant atmosphere for
innovation and improvement.
IIL
has research collaborations with several reputed
national and international institutes. To name a
few:
-
Thomas
Jefferson Medical School, USA - Monoclonal
antibodies
-
Onderstepoort
Veterinary Institute, South Africa - FMD
antigens
-
Institute
of Animal Health, UK - FMD Epidemiology
-
Indian
Veterinary Research Institute - PPR Vaccine
-
Veterinary
Technologies Corporation, USA - Brucellosis
Vaccine
-
Institute
of Cytology and Preventive Oncology - HPV
vaccine
-
Centre
for Disease Control (CDC), USA - Hepatitis A,
Rabies
-
Indian
Institute of Science - DNA vaccines, Hepatitis B
-
Centre
Hospitalier Universitaire Vaudois, Switzerland -
HPV oral vaccine.
-
Harvard
Medical School, USA - Polysaccharide vaccines
-
International
Vaccine Institute, Korea - Vaccines for GI
infections and Japanese Encephalitis
-
Institute
of Molecular Biology and Applied Ecology,
Germany - Plant vaccines
-
National
Institute of Health (NIH), USA - Vaccinia
vectors
-------------------------------------------------------------------------------------------------------------------
|
|
